Cargando…

Resectability, Resections, Survival Outcomes, and Quality of Life in Older Adult Patients with Metastatic Colorectal Cancer (the RAXO-Study)

Older adults are underrepresented in metastatic colorectal cancer (mCRC) studies and thus may not receive optimal treatment, especially not metastasectomies. The prospective Finnish real-life RAXO-study included 1086 any organ mCRC patients. We assessed repeated centralized resectability, overall su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lehtomäki, Kaisa, Soveri, Leena-Maija, Osterlund, Emerik, Lamminmäki, Annamarja, Uutela, Aki, Heervä, Eetu, Halonen, Päivi, Stedt, Hanna, Aho, Sonja, Muhonen, Timo, Ålgars, Annika, Salminen, Tapio, Kallio, Raija, Nordin, Arno, Aroviita, Laura, Nyandoto, Paul, Kononen, Juha, Glimelius, Bengt, Ristamäki, Raija, Isoniemi, Helena, Osterlund, Pia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218996/ https://www.ncbi.nlm.nih.gov/pubmed/37240646 http://dx.doi.org/10.3390/jcm12103541

Ejemplares similares

Health-Related Quality of Life in Metastatic Colorectal Cancer Patients Treated with Curative Resection and/or Local Ablative Therapy or Systemic Therapy in the Finnish RAXO-Study
por: Lehtomäki, Kaisa, et al.
Publicado: (2022)

Resectability, conversion, metastasectomy and outcome according to RAS and BRAF status for metastatic colorectal cancer in the prospective RAXO study
por: Uutela, Aki, et al.
Publicado: (2022)

Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study
por: Osterlund, Pia, et al.
Publicado: (2021)

Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study
por: Uutela, Aki, et al.
Publicado: (2022)

KRAS-G12C Mutation in One Real-Life and Three Population-Based Nordic Cohorts of Metastatic Colorectal Cancer
por: Osterlund, Emerik, et al.
Publicado: (2022)

Centralized repeated resectability assessment of patients with colorectal liver metastases during first-line treatment: prospective study
por: Isoniemi, H, et al.
Publicado: (2021)

Treatment response of colorectal cancer liver metastases to neoadjuvant or conversion therapy: a prospective multicentre follow-up study using MRI, diffusion-weighted imaging and (1)H-MR spectroscopy compared with histology (subgroup in the RAXO trial)
por: Uutela, A., et al.
Publicado: (2021)

Short-course preoperative radiotherapy increases pelvic fracture risk in rectal cancer
por: Vesa, Väliaho, et al.
Publicado: (2023)

Heterogeneous EGFR Gene Copy Number Increase Is Common in Colorectal Cancer and Defines Response to Anti-EGFR Therapy
por: Ålgars, Annika, et al.
Publicado: (2014)

A single-institution experience with bevacizumab in the treatment of metastatic colorectal cancer and in conjunction with liver resection
por: Osterlund, Pia, et al.
Publicado: (2014)

Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study
por: Osterlund, P., et al.
Publicado: (2022)

Recurrence Risk after Radical Colorectal Cancer Surgery—Less Than before, But How High Is It?
por: Osterman, Erik, et al.
Publicado: (2020)

Hypertension and overall survival in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy
por: Österlund, P, et al.
Publicado: (2011)

EGFR gene amplification is relatively common and associates with outcome in intestinal adenocarcinoma of the stomach, gastro-oesophageal junction and distal oesophagus
por: Birkman, Eva-Maria, et al.
Publicado: (2016)

Transient Changes in Serum CEA, CA19-9, CRP, YKL-40, and IL-6 during Adjuvant Chemotherapy and Survival of Patients with Colorectal Cancer
por: Lehtomäki, Kaisa, et al.
Publicado: (2023)

Detection of KRAS mutations in liquid biopsies from metastatic colorectal cancer patients using droplet digital PCR, Idylla, and next generation sequencing
por: Holm, Matilda, et al.
Publicado: (2020)

Sex differences in metastatic surgery following diagnosis of synchronous metastatic colorectal cancer
por: Ljunggren, Malin, et al.
Publicado: (2022)

Lung metastasectomy for colorectal cancer in the PulMiCC randomised controlled trial – Authors’ reply
por: Osterlund, Pia, et al.
Publicado: (2021)

Elevated serum YKL-40, IL-6, CRP, CEA, and CA19-9 combined as a prognostic biomarker panel after resection of colorectal liver metastases
por: Peltonen, Reetta, et al.
Publicado: (2020)

Gastric cancer: immunohistochemical classification of molecular subtypes and their association with clinicopathological characteristics
por: Birkman, Eva-Maria, et al.
Publicado: (2017)

Association of tumor-infiltrating T lymphocytes with intestinal-type gastric cancer molecular subtypes and outcome
por: Mansuri, Naziha, et al.
Publicado: (2020)

FHOD1 and FMNL1 formin proteins in intestinal gastric cancer: correlation with tumor-infiltrating T lymphocytes and molecular subtypes
por: Mansuri, Naziha, et al.
Publicado: (2021)

Perceived Barriers and Facilitators in Using Patient-Reported Outcome Systems for Cancer Care: Systematic Mapping Study
por: Laitio, Anna-Mari, et al.
Publicado: (2023)

Association between Computed Tomography-Determined Loss of Muscle Mass and Impaired Three-Month Survival in Frail Older Adults with Cancer
por: Tolonen, Antti, et al.
Publicado: (2023)

Lead Time and Prognostic Role of Serum CEA, CA19-9, IL-6, CRP, and YKL-40 after Adjuvant Chemotherapy in Colorectal Cancer
por: Lehtomäki, Kaisa, et al.
Publicado: (2021)

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer.
por: Pyrhönen, S., et al.
Publicado: (1995)

Helicobacter pylori and gastrointestinal symptoms in diagnostics and adjuvant chemotherapy of colorectal cancer
por: SOVERI, LEENA-MAIJA, et al.
Publicado: (2014)

Impact of deep learning-determined smoking status on mortality of cancer patients: never too late to quit
por: Karlsson, A., et al.
Publicado: (2021)

Associations between Response to Commonly Used Neo-Adjuvant Schedules in Rectal Cancer and Routinely Collected Clinical and Imaging Parameters
por: Karimi, Masoud, et al.
Publicado: (2022)

EGFR gene copy number assessment from areas with highest EGFR expression predicts response to anti-EGFR therapy in colorectal cancer
por: Ålgars, A, et al.
Publicado: (2011)

Reply: EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain?
por: Ålgars, A, et al.
Publicado: (2012)

Assessment of chemotherapy‐induced neurotoxicity using a point‐of‐care nerve conduction study device
por: Jokimäki, Anna, et al.
Publicado: (2022)

Impact of cholangitis on survival of patients with malignant biliary obstruction treated with percutaneous transhepatic biliary drainage
por: Niemelä, Jarmo, et al.
Publicado: (2023)

Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy for older patients with metastatic colorectal cancer: NORDIC 9
por: Winther, Stine Braendegaard, et al.
Publicado: (2017)

Smoking is an Independent Marker of Poor Prognosis in Cutaneous Melanoma
por: MATTILA, Kalle, et al.
Publicado: (2023)

Clinical pathways at Norwegian hospitals 2003–2007. A general overview and special focus on cerebral infarction
por: Petersen, Stein Østerlund, et al.
Publicado: (2008)

Cancer Occurrence After a Cerebral Venous Thrombosis: A Nationwide Registry Study
por: Sipilä, Jussi O.T., et al.
Publicado: (2022)

Manifestations of Fasting-Induced Fatty Liver and Rapid Recovery from Steatosis in Voles Fed Lard or Flaxseed Oil Lipids
por: Mustonen, Anne-Mari, et al.
Publicado: (2013)

To resect, or not to resect: that is the question…
por: Ng, Caecilia, et al.
Publicado: (2020)

Signaling pathways in human osteoclasts differentiation: ERK1/2 as a key player
por: Pennanen, Paula, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mo4829oo9udnj393lao6v8effg